154 related articles for article (PubMed ID: 35394184)
1. Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC.
Müller L; Kloeckner R; Mähringer-Kunz A; Stoehr F; Düber C; Arnhold G; Gairing SJ; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Hahn F
Eur Radiol; 2022 Sep; 32(9):6302-6313. PubMed ID: 35394184
[TBL] [Abstract][Full Text] [Related]
2. Low bone mineral density is a prognostic factor for elderly patients with HCC undergoing TACE: results from a multicenter study.
Müller L; Mähringer-Kunz A; Auer TA; Fehrenbach U; Gebauer B; Haubold J; Theysohn JM; Kim MS; Kleesiek J; Diallo TD; Eisenblätter M; Bettinger D; Steinle V; Mayer P; Zopfs D; Pinto Dos Santos D; Kloeckner R
Eur Radiol; 2023 Feb; 33(2):1031-1039. PubMed ID: 35986768
[TBL] [Abstract][Full Text] [Related]
3. Real-time automatic prediction of treatment response to transcatheter arterial chemoembolization in patients with hepatocellular carcinoma using deep learning based on digital subtraction angiography videos.
Zhang L; Jiang Y; Jin Z; Jiang W; Zhang B; Wang C; Wu L; Chen L; Chen Q; Liu S; You J; Mo X; Liu J; Xiong Z; Huang T; Yang L; Wan X; Wen G; Han XG; Fan W; Zhang S
Cancer Imaging; 2022 May; 22(1):23. PubMed ID: 35549776
[TBL] [Abstract][Full Text] [Related]
4. Imaging Predictors of Survival in Patients with Single Small Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Park C; Kim JH; Kim PH; Kim SY; Gwon DI; Chu HH; Park M; Hur J; Kim JY; Kim DJ
Korean J Radiol; 2021 Feb; 22(2):213-224. PubMed ID: 32901464
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of splenic volume in hepatocellular carcinoma patients receiving transarterial chemoembolization.
Dai HT; Chen B; Tang KY; Zhang GY; Wen CY; Xiang XH; Yang JY; Guo Y; Lin R; Huang YH
J Gastrointest Oncol; 2021 Jun; 12(3):1141-1151. PubMed ID: 34295563
[TBL] [Abstract][Full Text] [Related]
6. Residual convolutional neural network for predicting response of transarterial chemoembolization in hepatocellular carcinoma from CT imaging.
Peng J; Kang S; Ning Z; Deng H; Shen J; Xu Y; Zhang J; Zhao W; Li X; Gong W; Huang J; Liu L
Eur Radiol; 2020 Jan; 30(1):413-424. PubMed ID: 31332558
[TBL] [Abstract][Full Text] [Related]
7. Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma.
Labeur TA; Takkenberg RB; Klümpen HJ; van Delden OM
Cardiovasc Intervent Radiol; 2019 Feb; 42(2):230-238. PubMed ID: 30488302
[TBL] [Abstract][Full Text] [Related]
8. Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Parikh ND; Zhang P; Singal AG; Derstine BA; Krishnamurthy V; Barman P; Waljee AK; Su GL
Cancer Res Treat; 2018 Apr; 50(2):530-537. PubMed ID: 28602057
[TBL] [Abstract][Full Text] [Related]
9. Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study.
Wang ZX; Wang EX; Bai W; Xia DD; Mu W; Li J; Yang QY; Huang M; Xu GH; Sun JH; Li HL; Zhao H; Wu JB; Yang SF; Li JP; Li ZX; Zhang CQ; Zhu XL; Zheng YB; Wang QH; Li J; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH; On Behalf Of China Hcc-Tace Study Group
World J Gastroenterol; 2020 Feb; 26(6):657-669. PubMed ID: 32103874
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Survival Factors of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.
Rohan T; Uher M; Matkulčík P; Zavadil J; Ostřížková L; Kiss I; Andrašina T; Válek V
Klin Onkol; 2020; 33(3):214-219. PubMed ID: 32683878
[TBL] [Abstract][Full Text] [Related]
11. Quantitative washout in patients with hepatocellular carcinoma undergoing TACE: an imaging biomarker for predicting prognosis?
Müller L; Hahn F; Jungmann F; Mähringer-Kunz A; Stoehr F; Halfmann MC; Pinto Dos Santos D; Hinrichs J; Auer TA; Düber C; Kloeckner R
Cancer Imaging; 2022 Jan; 22(1):5. PubMed ID: 35016731
[TBL] [Abstract][Full Text] [Related]
12. Response prediction of hepatocellular carcinoma undergoing transcatheter arterial chemoembolization: unlocking the potential of CT texture analysis through nested decision tree models.
Vosshenrich J; Zech CJ; Heye T; Boldanova T; Fucile G; Wieland S; Heim MH; Boll DT
Eur Radiol; 2021 Jun; 31(6):4367-4376. PubMed ID: 33274405
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Fehrenbach U; Auer TA; Gebauer B; Kloeckner R
United European Gastroenterol J; 2022 Feb; 10(1):41-53. PubMed ID: 34918471
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
[TBL] [Abstract][Full Text] [Related]
15. T1 relaxation time analysis in predicting hepatic dysfunction and prognosis in patients with HCC undergoing transarterial chemoembolization.
Huang H; Qiao H; Jiang J; Yan J; Wen Q; Gen D; Wu Q
Eur J Radiol; 2023 Aug; 165():110938. PubMed ID: 37392548
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of spleen volume measurement using computed tomography in patients with compensated chronic liver disease from hepatitis B viral infection.
Yoo J; Kim SW; Lee DH; Bae JS; Cho EJ
Eur Radiol; 2021 Mar; 31(3):1432-1442. PubMed ID: 32880698
[TBL] [Abstract][Full Text] [Related]
17. Parametric response mapping cut-off values that predict survival of hepatocellular carcinoma patients after TACE.
Nörthen A; Asendorf T; Shin HO; Hinrichs JB; Werncke T; Vogel A; Kirstein MM; Wacker FK; Rodt T
Abdom Radiol (NY); 2018 Dec; 43(12):3288-3300. PubMed ID: 29680967
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE).
Ma W; Jia J; Wang S; Bai W; Yi J; Bai M; Quan Z; Yin Z; Fan D; Wang J; Han G
Theranostics; 2014; 4(7):736-44. PubMed ID: 24883123
[TBL] [Abstract][Full Text] [Related]
19. Prediction of post-TACE necrosis of hepatocellular carcinoma usingvolumetric enhancement on MRI and volumetric oil deposition on CT, with pathological correlation.
Najmi Varzaneh F; Pandey A; Aliyari Ghasabeh M; Shao N; Khoshpouri P; Pandey P; Zarghampour M; Fouladi D; Liddell R; Anders RA; Kamel IR
Eur Radiol; 2018 Jul; 28(7):3032-3040. PubMed ID: 29383518
[TBL] [Abstract][Full Text] [Related]
20. [Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC)].
Herber SC; Otto G; Woerns M; Moench C; Kanzler S; Junginger T; Schneider J; Schuchmann M; Kummer I; Manzl N; Düber C; Pitton MB
Rofo; 2007 Mar; 179(3):289-99. PubMed ID: 17325996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]